Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Of science interest

<< Previous

Bullboard Posts

Next >>

Comment by DJDawgon Dec 19, 2024 12:44pm

109 Views

Post# 36370564

RE:RE:Of science interest

That meant to be a dash.

No intervention = a certain amount of reactive oxygen (always some in all cells)= 1
Ruth/Rad = 1.6 times the reactive oxgyen of control baseline
Ruth/Rad/Met = 2.4 times the reactive oxgyen of control baseline

Reactive oxgyen, once released inside a cell is highly damaging and destructive. So much so that cells often die quickly due to internal disruption

<< Previous

Bullboard Posts

Next >>

Critical materials crisis: Diversifying away from China’s monopoly